The end of prescribing ivermectin for COVID

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Dr Linda Calabresi

 

It’s been a tough week for GPs who want to march to the beat of their own drum with regard to COVID.

On September 10, the TGA effectively put the kibosh on GPs prescribing ivermectin for anything other than its listed indication, namely scabies and other parasitic infections.

That means no more scripts to prevent or treat COVID-19, much to the outrage of a small but very vocal group of advocates including patients, doctors, and a certain, very vocal MP. Letters have been written, press releases published.

Claims that the TGA’s decision will damage public health by increasing mortality and that ‘all doctors confirm that this is an early, safe and effective treatment for Covid’ tend to suggest hyperbole.

Nonetheless, the supporters of ivermectin remain firmly convinced that this drug, when given with doxycycline and zinc as triple therapy has benefits for Covid, particularly for those patients with the infection who are not sick enough to be hospitalised. They claim there is evidence to support its use.

But ivermectin is just one of an array of alternative therapeutic options that have been suggested for Covid-19. Right from the very beginning with hydroxychloroquine and vitamin D to now with ivermectin and zinc people have been on the hunt for out-of-the ordinary therapies to prevent or treat the disease.

So how does this play out in general practice? Who is advocating what and how much does patient pressure come into the equation?

According to a recent Healthed survey it appears GPs remain a fairly conservative (aka safe) bunch of professionals. Of the more than 720 GPs who completed online questionnaire, less than half (44.26%) were promoting anything in the way of drugs or micronutrients to help prevent the infection. Just over a third (34.72%) advocated vitamin D, while more than a quarter (26.28%) promoted vitamin C to prevent or treat Covid. Less than one in five (18.67%) GPs were recommending zinc.

In terms of ivermectin, almost 42% of GPs had been asked about this drug and its role in Covid. And almost a quarter of GPs (24.48%) said they had had at least one patient come in and specifically ask for a script for this drug. Not huge numbers but certainly represents a degree of patient pressure.

And where are patients getting the information on which their request is based? Well, according to this survey at least, almost 90% of patients are reporting the source of their ivermectin information as social media. Sign of the times.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm & Prof Jeremy Grummet

A/Prof Ralph Audehm & Prof Jeremy Grummet

New Prostate Cancer Screening Guidelines – Case-Based Explanation for GP

Dr Katherine Spira

Dr Katherine Spira

Acute Migraine Management

A/Prof Gary Kilov AM

A/Prof Gary Kilov AM

Continuous Glucose Monitoring Update – Why it will Soon Become Standard Care

Dr Aviv Pudipeddi & Dr David Lim

Dr Aviv Pudipeddi & Dr David Lim

Faecal Calprotectin – A Practical Guide to the Test and the New Item Number

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.